BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
FOXP1
,
Coagulation
,
Ischemia
,
Embryo
,
Autoimmunity
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors epoprostenol
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Leukemic pre-B cells treated with different retinoids in combination with IKZF1-IK6 overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
Use of the Prostacyclin Receptor Agonist Selexipag in Patients With Pulmonary Arterial Hypertension …
Pharmacological characteristics and clinical study results of Selexipag (UptraviĀ® tablets), a select…
Prostaglandin I2 (PGI2) inhibits Brucella abortus internalization in macrophages via PGI2 receptor s…
Efficacy and safety of non-prostanoid prostacyclin receptor agonist for pulmonary hypertension: A me…
Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH RESISTANT ARTERIAL HYPE…
Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ